Can ketamine plus therapy curb suicidal thoughts? new trial aims to find out.
NCT ID NCT07569198
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests whether combining ketamine infusions with dialectical behavioural therapy (DBT) can reduce suicidal thoughts more effectively than a placebo plus DBT. About 120 adults with borderline personality disorder and treatment-resistant depression or bipolar disorder will receive six infusions and six months of therapy. The goal is to see if this combination leads to faster and stronger improvements in suicidal thinking.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER (BD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto Western Hospital
RECRUITINGToronto, Ontario, M5T 2S8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can peer mentors help gay men with HIV stay in care?
- Hope in action: peer support may curb suicide risk in youth facing psychosis
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can the immune system hold the key to treating resistant mental illness?
- Can tailored brain zaps beat standard therapy for depression?